title: Endometrial ablation with the NovaSure system in Iran.
abstract: OBJECTIVE
  To evaluate the rate of response to treatment with the NovaSure endometrial ablation device among Iranian women with menorrhagia.
  
  
  METHODS
  Twenty 35-50-year-old women with menorrhagia who were referred to Arash Hospital, Tehran, Iran, in 2008 were enrolled. They underwent endometrial ablation via the NovaSure system and were followed-up for 2 years.
  
  
  RESULTS
  The incidence of amenorrhea was 30.0% at the end of the 2-year follow-up period. Hypomenorrhea was reported by 40.0% of women. The mean number of days of bleeding per month decreased significantly, from 30.0 ± 6.4 days before treatment to 3.1 ± 2.6 days after 2 years (P < 0.001). The severity of bleeding decreased significantly within 2 years after treatment (P < 0.001). In total, 85.0% of women were satisfied and 90.0% had responded to treatment-as defined by amenorrhea, hypomenorrhea, or return to normal menstruation.
  
  
  CONCLUSIONS
  The NovaSure system is effective and should be considered by gynecologists for the treatment of menorrhagia.
authors.affiliation: Department of Gynecology, Arash Hospital, Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: Zahra
authors.initials: Z
authors.lastname: Asgari
authors.forename: Ashraf
authors.initials: A
authors.lastname: Moini
authors.forename: Haydeh
authors.initials: H
authors.lastname: Samiee
authors.forename: Afsaneh
authors.initials: A
authors.lastname: Tehranian
authors.forename: Sima
authors.initials: S
authors.lastname: Mozafar-Jalali
authors.forename: Somayeh
authors.initials: S
authors.lastname: Sabet
mesh_terms: D000328:Adult; D055356:Endometrial Ablation Techniques / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015907:Hysteroscopy / Q000379:methods*; D007492:Iran; D008595:Menorrhagia / Q000601:surgery*; D008875:Middle Aged; D017060:Patient Satisfaction; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome